Ly6C Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2018 Mar 3

PMID 29496661

Citations 108

Authors

Andrew Kimball

Matthew Schaller

Amrita Joshi

Frank M Davis

Aaron DenDekker

Anna Boniakowski

Jennifer Bermick

Andrea Obi

Bethany Moore

Peter K Henke

Steve L Kunkel

Katherine A Gallagher

Affiliations

Soon will be listed here.

Abstract

Objective: Wound monocyte-derived macrophage plasticity controls the initiation and resolution of inflammation that is critical for proper healing, however, in diabetes mellitus, the resolution of inflammation fails to occur. In diabetic wounds, the kinetics of blood monocyte recruitment and the mechanisms that control in vivo monocyte/macrophage differentiation remain unknown.

Approach And Results: Here, we characterized the kinetics and function of Ly6C [Lin (CD3CD19NK1.1Ter-119) Ly6GCD11b] and Ly6C [Lin (CD3CD19NK1.1Ter-119) Ly6GCD11b] monocyte/macrophage subsets in normal and diabetic wounds. Using flow-sorted -labeled Ly6C monocyte/macrophages, we show Ly6C cells transition to a Ly6C phenotype in normal wounds, whereas in diabetic wounds, there is a late, second influx of Ly6C cells that fail transition to Ly6C. The second wave of Ly6C cells in diabetic wounds corresponded to a spike in MCP-1 (monocyte chemoattractant protein-1) and selective administration of anti-MCP-1 reversed the second Ly6C influx and improved wound healing. To examine the in vivo phenotype of wound monocyte/macrophages, RNA-seq-based transcriptome profiling was performed on flow-sorted Ly6C [LinLy6GCD11b] and Ly6C [LinLy6GCD11b] cells from normal and diabetic wounds. Gene transcriptome profiling of diabetic wound Ly6C cells demonstrated differences in proinflammatory and profibrotic genes compared with controls.

Conclusions: Collectively, these data identify kinetic and functional differences in diabetic wound monocyte/macrophages and demonstrate that selective targeting of CD11bLy6C monocyte/macrophages is a viable therapeutic strategy for inflammation in diabetic wounds.

Citing Articles

Exploring the Therapeutic Potential of Antibiotics in Hyperglycemia-Induced Macrophage Dysfunctions.

Yossapol M, Srinontong P, Aengwanich W, Panil M, Somsup S, Odoi J Antibiotics (Basel). 2025; 14(2).

PMID: 40001441 PMC: 11851781. DOI: 10.3390/antibiotics14020198.

m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif-1α axis.

Zhu S, Jiang L, Liu X, Chen C, Luo X, Jiang S FASEB J. 2025; 39(2):e70332.

PMID: 39831513 PMC: 11744739. DOI: 10.1096/fj.202403014R.

The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational....

Rehak L, Giurato L, Monami M, Meloni M, Scatena A, Panunzi A J Clin Med. 2024; 13(23).

PMID: 39685690 PMC: 11642624. DOI: 10.3390/jcm13237230.

Therapeutic Properties of M2 Macrophages in Chronic Wounds: An Innovative Area of Biomaterial-Assisted M2 Macrophage Targeted Therapy.

Nazari M, Taremi S, Elahi R, Mostanadi P, Esmeilzadeh A Stem Cell Rev Rep. 2024; 21(2):390-422.

PMID: 39556244 DOI: 10.1007/s12015-024-10806-3.

Association between inflammatory markers and anemia in patients with diabetic foot ulcer.

Li J, Chen W, Wen X, Jin X, Zhu P, Jiang C Biomark Med. 2024; 18(23):1037-1047.

PMID: 39535133 PMC: 11633438. DOI: 10.1080/17520363.2024.2421159.

References

Mirza R, Koh T . Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine. 2011; 56(2):256-64. DOI: 10.1016/j.cyto.2011.06.016. View

Faglia E, Favales F, Morabito A . New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. Diabetes Care. 2001; 24(1):78-83. DOI: 10.2337/diacare.24.1.78. View

Taylor P, Gordon S . Monocyte heterogeneity and innate immunity. Immunity. 2003; 19(1):2-4. DOI: 10.1016/s1074-7613(03)00178-x. View

Van Furth R, COHN Z . The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968; 128(3):415-35. PMC: 2138527. DOI: 10.1084/jem.128.3.415. View

Sica A, Mantovani A . Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122(3):787-95. PMC: 3287223. DOI: 10.1172/JCI59643. View

Reiber G, Vileikyte L, Boyko E, Del Aguila M, Smith D, Lavery L . Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999; 22(1):157-62. DOI: 10.2337/diacare.22.1.157. View

Yona S, Kim K, Wolf Y, Mildner A, Varol D, Breker M . Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013; 38(1):79-91. PMC: 3908543. DOI: 10.1016/j.immuni.2012.12.001. View

Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy A, Friedlander G . Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012; 37(6):1076-90. DOI: 10.1016/j.immuni.2012.08.026. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

10.

Geissmann F, Manz M, Jung S, Sieweke M, Merad M, Ley K . Development of monocytes, macrophages, and dendritic cells. Science. 2010; 327(5966):656-61. PMC: 2887389. DOI: 10.1126/science.1178331. View

11.

Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong C, Petri B . A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J Exp Med. 2015; 212(4):447-56. PMC: 4387291. DOI: 10.1084/jem.20141539. View

12.

Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S . Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007; 317(5838):666-70. DOI: 10.1126/science.1142883. View

13.

Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C, Leal E . Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012; 61(11):2937-47. PMC: 3478547. DOI: 10.2337/db12-0227. View

14.

Wynn T, Vannella K . Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016; 44(3):450-462. PMC: 4794754. DOI: 10.1016/j.immuni.2016.02.015. View

15.

Lauvau G, Chorro L, Spaulding E, MHoma Soudja S . Inflammatory monocyte effector mechanisms. Cell Immunol. 2014; 291(1-2):32-40. PMC: 4457438. DOI: 10.1016/j.cellimm.2014.07.007. View

16.

Medzhitov R . Origin and physiological roles of inflammation. Nature. 2008; 454(7203):428-35. DOI: 10.1038/nature07201. View

17.

Cipolletta C, Ryan K, Hanna E, Trimble E . Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes. 2005; 54(9):2779-86. DOI: 10.2337/diabetes.54.9.2779. View

18.

Swirski F, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P . Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325(5940):612-6. PMC: 2803111. DOI: 10.1126/science.1175202. View

19.

Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C . Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 2010; 5(3):e9539. PMC: 2832020. DOI: 10.1371/journal.pone.0009539. View

20.

Wong K, Tai J, Wong W, Han H, Sem X, Yeap W . Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011; 118(5):e16-31. DOI: 10.1182/blood-2010-12-326355. View